Cargando…
Role of multimodality therapy in cIIIA-N2 non–small cell lung cancer: perspective(§)
A number of promising new approaches for both local and systemic control of locally advanced non–small cell lung cancer have been examined in clinical trials, aimed at improving the patient survival. Development of better systemic therapies by adopting newer agents (such as epidermal growth factor r...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5144660/ https://www.ncbi.nlm.nih.gov/pubmed/27702837 http://dx.doi.org/10.1093/jjco/hyw131 |